Ran BP-4, also known as Ran Binding Protein 4, is a part of the Ran (Ras-related nuclear protein) system, a critical component in the regulation of transport across the nuclear envelope in eukaryotic cells. Ran is a small GTPase, a type of protein that can bind and hydrolyze GTP, and it is involved in the control of various cellular processes, including nuclear transport, mitotic spindle assembly, and nuclear envelope assembly.Ran BP-4 functions as a binding protein for Ran, specifically interacting with its GTP-bound form. This interaction is essential for the regulation of Ran's activity and, consequently, for the proper functioning of nuclear transport. In the nucleus, Ran exists predominantly in its GTP-bound form, while in the cytoplasm, it is mostly in the GDP-bound form. This gradient is crucial for the directionality of nuclear transport.
The Ran GTPase cycle, regulated by various Ran binding proteins and Ran GTPase-activating proteins (RanGAPs), is central to the transport of proteins and RNA between the nucleus and cytoplasm. Cargo proteins with nuclear localization signals (NLS) are transported into the nucleus by importins, while exportins mediate the export of proteins with nuclear export signals (NES). Ran BP-4, by interacting with Ran-GTP, influences these processes.In addition to its role in nuclear transport, the Ran system, and by extension, proteins like Ran BP-4, are involved in cell cycle regulation, particularly during mitosis. The Ran GTPase system ensures the proper formation and function of the mitotic spindle, which is crucial for chromosome segregation during cell division.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Leptomycin B inhibits exportin 1 (CRM1), a key factor in nuclear export, which may indirectly affect Ran BP-4 function in nuclear transport. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the Golgi apparatus and could indirectly influence Ran BP-4 activity by affecting cellular transport mechanisms. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine is a CDK inhibitor, affecting cell cycle progression, which might indirectly impact Ran BP-4 activity through cell cycle regulation. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and can influence spindle assembly, potentially affecting Ran BP-4's role in mitosis. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubules, affecting spindle assembly and potentially impacting Ran BP-4's mitotic functions. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
ML141 is a Cdc42 inhibitor, affecting cytoskeleton organization, which could indirectly influence Ran BP-4 activity. | ||||||
Ivermectin | 70288-86-7 | sc-203609 sc-203609A | 100 mg 1 g | $57.00 $77.00 | 2 | |
Ivermectin, known for its antiparasitic properties, has been shown to affect nuclear transport and may indirectly impact Ran BP-4. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
Blebbistatin inhibits myosin II, affecting cytoskeleton dynamics, which might indirectly influence Ran BP-4 activity. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
ZM447439 is an Aurora kinase inhibitor, affecting spindle assembly and chromosome segregation, potentially impacting Ran BP-4. | ||||||
Purvalanol A | 212844-53-6 | sc-224244 sc-224244A | 1 mg 5 mg | $72.00 $297.00 | 4 | |
Purvalanol A is a cyclin-dependent kinase inhibitor, potentially affecting cell cycle processes linked to Ran BP-4's function. | ||||||